Bincy Abraham, M.D. Download Headshot

Bincy Abraham, MD, MS

  • Houston Methodist gastroenterologist
  • Inflammatory bowel disease program director, Houston Methodist Hospital Lynda K. and David M. Underwood Center for Digestive Disorders
  • Fondren Distinguished Professor in Inflammatory Bowel Disease, Houston Methodist Hospital Department of Medicine
  • Associate Professor of Clinical Medicine, Houston Methodist Institute for Academic Medicine
Media Contact: Gale Smith , 832.667.5843

Bincy Abraham, MD, MS

Request Interview
Media Contact: Gale Smith , 832.667.5843

Areas of Expertise

  • Capsule endoscopy
  • Clinical Trials
  • Crohn's disease
  • Pregnancy & inflammatory bowel disease
  • Transition of care in inflammatory bowel disease
  • Ulcerative colitis

Credentials

RESIDENCY
University of Texas Medical Branch - Galveston, TX | 2005
INTERNSHIP
University of Texas Medical Branch - Galveston, TX | 2003
MEDICAL SCHOOL
University of Texas Medical Branch at Galveston | 2002
BOARD CERTIFICATION
Gastroenterology | American Board of Internal Medicine
FELLOWSHIP
Gastroenterology - University of Texas Medical Branch - Galveston, TX | 2008

Publications

Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis
Ouranos, K, Saleem, H, Vassilopoulos, S, Vassilopoulos, A, Mylona, EK, Shehadeh, F, Kalligeros, M, Abraham, BP & Mylonakis, E 2025, , Inflammatory bowel diseases, vol. 31, no. 1, pp. 37-51. https://doi.org/10.1093/ibd/izae031

Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study
Long, MD, Kane, S, Beaulieu, D, Abraham, B, Zhang, X & Mahadevan, U 2024, , Clinical and translational gastroenterology, vol. 15, no. 12, pp. e00795. https://doi.org/10.14309/ctg.0000000000000795

Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date
Glassner, K, Fan, C, Irani, M & Abraham, BP 2024, , Clinical and Experimental Gastroenterology, vol. 17, pp. 337-345. https://doi.org/10.2147/CEG.S391706

AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary
Chavannes, M, Dolinger, MT, Cohen-Mekelburg, S & Abraham, B 2024, , Clinical Gastroenterology and Hepatology, vol. 22, no. 9, pp. 1790-1795.e1. https://doi.org/10.1016/j.cgh.2024.04.039

Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
Ansari, M, Glassner, K, Irani, M, Saleh, A, Wang, L, Ezeana, C, Wong, S, Perry, C & Abraham, B 2024, , Journal of Digestive Diseases, vol. 25, no. 2, pp. 91-99. https://doi.org/10.1111/1751-2980.13261

Choosing Therapy for Moderate to Severe Crohn's Disease
Irani, M & Abraham, B 2024, , Journal of the Canadian Association of Gastroenterology, vol. 7, no. 1, pp. 1-8. https://doi.org/10.1093/jcag/gwad023

Role of the industry representative in the practice of gastroenterology and GI endoscopy
(ASGE ARIA Committee Chair) 2024, , Gastrointestinal Endoscopy, vol. 99, no. 3, pp. 307-313. https://doi.org/10.1016/j.gie.2023.10.057

Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
Saleh, A, Stading, R, Miroballi, N, Glassner, K & Abraham, BP 2024, , Journal of Digestive Diseases, vol. 25, no. 4, pp. 214-221. https://doi.org/10.1111/1751-2980.13264

Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn’s Disease
Moskow, J, Thurston, T, Saleh, A, Shah, A, Abraham, BP & Glassner, K 2024, , Digestive Diseases and Sciences, vol. 69, no. 8, pp. 2944-2954. https://doi.org/10.1007/s10620-024-08471-0

WHAT IS THE ROLE OF PROBIOTICS FOR PATIENTS WITH IBD?
Glassner, K & Abraham, BP 2024, in Curbside Consultation in IBD: 49 Clinical Questions. CRC Press, pp. 143-147. https://doi.org/10.1201/9781003523567-28

Irritable Bowel Syndrome in Women With IBD
Abraham, BP, Glassner, KL & Quigley, EM 2024, . in Women’s Health in IBD: The Spectrum of Care From Birth to Adulthood. CRC Press, pp. 195-212.


Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication
Maconi, G, Lepore, F, Saleh, A, Saibeni, S, Bezzio, C, Cheli, S, Massari, A, Gridavilla, D, Ferretti, F, Cannatelli, R, Ardizzone, S, Clementi, E & Abraham, B 2024, , Digestive and Liver Disease, vol. 56, no. 12, pp. 2052-2059. https://doi.org/10.1016/j.dld.2024.05.026

Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series
Thomas, B, Moskow, J, Garza, M, Warren, B, Abraham, B & Glassner, K 2023, , ACG case reports journal, vol. 10, no. 12, pp. e01221. https://doi.org/10.14309/crj.0000000000001221


The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Abraham, BP, Fan, C, Thurston, T, Moskow, J & Malaty, HM 2023, , Nutrients, vol. 15, no. 22, 4847. https://doi.org/10.3390/nu15224847

Real-World Impact of Infliximab Precision-Guided Dosing on Management of Patients With IBD
Abraham, BP, Ziring, DA, Dervieux, T, Han, PA, Shim, A & Battat, R 2023, , American Journal of Managed Care, vol. 29, no. 12 Suppl, pp. S227-S235. https://doi.org/10.37765/AJMC.2023.89447

The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
Saleh, A, Parsa, S, Garza, M, Quigley, EMM & Abraham, BP 2023, , Digestive Diseases, vol. 41, no. 4, pp. 656-665. https://doi.org/10.1159/000529591

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
Saleh, A & Abraham, BP 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad027, pp. otad027. https://doi.org/10.1093/crocol/otad027

Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started
Abraham, BP, Reddy, D & Saleh, A 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad043, pp. otad043. https://doi.org/10.1093/crocol/otad043

Languages

English